Centessa Pharmaceuticals

NASDAQ: CNTA · Real-Time Price · USD
17.92
0.28 (1.59%)
At close: Aug 15, 2025, 1:21 PM

Centessa Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
383.22M 128.03M 393.64M 595.08M
Short-Term Investments
98.96M 128.52M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.05M 2.55M 45.98M 34.39M
Receivables
45.3M 39.15M 26.72M 16.81M
Inventory
n/a n/a -29.99M -17.81M
Other Current Assets
1.78M 1.62M 3.27M 993K
Total Current Assets
536.41M 315.09M 393.64M 595.08M
Property-Plant & Equipment
11.76M 12.95M 1.17M 162K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
40.39M 45.15M 50.66M 34.55M
Total Assets
576.8M 360.25M 444.31M 629.63M
Account Payables
7.14M 11.81M 13.84M 7.3M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
10.18M 839K 2.27M 871K
Total Current Liabilities
58M 39.38M 38.34M 24.64M
Long-Term Debt
108.94M 75.7M 69.8M 75.7M
Other Long-Term Liabilities
29K 29K n/a 37.74M
Total Long-Term Liabilities
117.25M 84.62M 108.14M 138.08M
Total Liabilities
175.25M 124M 108.14M 138.08M
Total Debt
117.23M 84.59M 69.8M 75.7M
Common Stock
359K 273K 265K 252K
Retained Earnings
-988.7M -752.95M -601.86M -385.65M
Comprehensive Income
4.21M 1.49M -1.5M 688K
Shareholders Equity
401.55M 236.24M 336.17M 491.55M
Total Investments
98.96M 128.52M n/a n/a